Analgesic ketamine product development
Active Other Transaction Agreement Awarded Last action
- Contract number
- HT9427269E001
- Awardee
-
IX Biopharma LTD. UEI UJ73DZNC8HW4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $7,127,731
Award facts
- Contract value 17% obligated
-
- $7,127,730.91 Current, with exercised options
- $40,954,914.00 Potential, with all options
- Completion date 23% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- Not on record
- Competition
- Not Competed Only One Source
- Pricing
- Other
- Place of performance
- Singapore
Award details come from SAM.gov/FPDS.
About this award
The Medical Command awarded an Other Transaction Agreement to IX Biopharma LTD. for analgesic ketamine product development, with a ceiling value of $40,954,914 and an award date of February 9, 2026. The agreement sits outside the FAR and operates under alternative transactional authority.
Work is performed in Singapore. The ultimate completion date is February 8, 2029.
Quick answers
Who was awarded contract HT9427269E001?
HT9427269E001 was awarded to IX Biopharma LTD. by Defense Health Agency (Department of Defense) on February 9, 2026.
How much is contract HT9427269E001 worth?
The government has obligated $7,127,731 on HT9427269E001. Its potential value, with all options, is $40,954,914.
Which agency awarded contract HT9427269E001?
Defense Health Agency (Department of Defense) awarded HT9427269E001, with funding from Medical Command (Department of the Army).
Was contract HT9427269E001 competed?
The extent of competition for HT9427269E001 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award